Single-Use Bioreactors Market worth $9.58 billion by 2031
The report "Single-Use Bioreactors Market by Product [System (By Scale), Bags (2D, 3D), Assemblies], Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031", is projected to grow from USD 5.43 billion in 2026 and to reach USD 9.58 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 12.0% during the forecast period.
Browse 585 market data Tables and 60 Figures spread through 460 Pages and in-depth TOC on "Single-Use Bioreactors Market by Product [System (By Scale), Bags (2D, 3D), Assemblies], Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html
The single-use bioreactors market is witnessing sustained growth, supported by increasing biologics and biosimilar manufacturing, expanding vaccine production, rising investment in cell & gene therapies, and continued growth in outsourced bioprocessing. Demand for flexible, scalable, and contamination-controlled production is encouraging wider adoption of single-use bioreactor systems across process development, clinical manufacturing, and commercial bioproduction. These platforms are increasingly integrated with disposable bags, fluid-transfer assemblies, sensors, controllers, and process analytical technologies to improve operational efficiency and process consistency. Advances in mixing performance, oxygen transfer, film durability, automation, and perfusion capability are enabling broader use in monoclonal antibody, recombinant protein, viral vector, and advanced therapy manufacturing. The transition toward modular facilities, closed processing, high-cell-density cultivation, and digitally connected upstream workflows is further strengthening adoption. In addition, growing reliance on CDMOs and CROs for process development, scale-up, and biologics production is expected to support continued investment in single-use infrastructure capable of accommodating multiple products, variable batch sizes, and shorter manufacturing timelines.
By product, the single-use bioreactor systems segment accounted for the largest share of the single-use bioreactors market in 2025.
By product, the single-use bioreactors market is segmented into single-use bioreactor systems, single-use bags, single-use assemblies, and other products. Single-use bioreactor systems are further categorized by scale into ≤10 L, 11–100 L, 101–500 L, 501–1,500 L, and ≥1,500 L. The systems segment dominated the market in 2025 due to its higher unit value, expanding installed base, and growing deployment across process development and commercial manufacturing. Within this segment, the 501–1,500 L category accounted for the largest share in 2025, supported by its extensive use in clinical- and commercial-scale production of monoclonal antibodies, recombinant proteins, vaccines, and biosimilars. These systems provide an effective balance between production capacity, operational flexibility, and scalability for multiproduct biomanufacturing facilities.
By process mode, the perfusion/continuous mode segment is estimated to register the highest growth in the single-use bioreactors market during the forecast period.
Based on process mode, the single-use bioreactors market is segmented into batch, fed-batch, and perfusion/continuous process modes. The perfusion/continuous process mode segment is expected to record the highest growth rate during the forecast period, driven by increasing demand for intensified and high-cell-density bioprocessing. Continuous media supply and product removal enable higher volumetric productivity, improved product quality, and longer production runs compared with conventional processes. The growing adoption of cell-retention technologies, automated monitoring, and perfusion-ready single-use bioreactors is further supporting segment growth. Demand is particularly increasing in monoclonal antibody, recombinant protein, viral vector, and cell & gene therapy manufacturing, where higher throughput and reduced facility footprints are important.
North America accounted for the largest share of the single-use bioreactors market in 2025.
The global single-use bioreactors market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America held the largest market share, supported by its established biopharmaceutical industry, substantial biologics R&D activity, mature CDMO ecosystem, and early adoption of disposable manufacturing technologies. The US remained the major contributor owing to its extensive pipelines for monoclonal antibodies, vaccines, recombinant proteins, viral vectors, and cell & gene therapies. Continued investment in modular facilities, process intensification, and flexible commercial-scale production is increasing demand for single-use systems, bags, assemblies, sensors, and controllers. The presence of leading bioprocessing suppliers, advanced regulatory capabilities, and growing adoption of closed and automated upstream workflows further strengthen the region’s position.
Key players in the single-use bioreactors market include Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kühner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Single-Use Bioreactors Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
